Skip to content

BDX vs JNJ: Dividend Comparison

BDX$215.83
Becton Dickinson & Co
Health Care
vs
JNJ$278.81
Johnson & Johnson
Health Care

Dividend data as of

Becton Dickinson & Co (BDX) and Johnson & Johnson (JNJ) are both in the Health Care sector, making them natural rivals for dividend investors. Both stocks offer similar yields — BDX at 1.97% and JNJ at 1.90%. For dividend growth, BDX leads with a 5-year CAGR of 9.3% versus JNJ's 5.0%. BDX holds the edge in dividend safety with a "Moderate" rating. BDX is a Dividend Aristocrat while JNJ is a Dividend King.

Verdict

Best for Income
BDX
Higher yield at 1.97%
Best for Growth
BDX
5yr CAGR of 9.3%
Best for Safety
BDX
Rated "Moderate"

Track BDX and JNJ in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan (1 portfolio, 10 holdings).

30-day free brokerage sync trial. No credit card. Then from $9.99/month. Choosing a tracker? See the best dividend trackers compared.

Metric
Price
$215.83
$278.81
Dividend Yield
1.97%
1.90%
Annual Dividend
$4.24
$5.36
5yr Div CAGR
9.3%
5.0%
3yr Div CAGR
11.6%
4.4%
Consecutive Years
42
61
Payout Ratio
72.49%
80.12%
P/E Ratio
—
—
Market Cap
—
—
Income on $10k
$197/yr
$190/yr

Yield Analysis

BDX
1.97%
JNJ
1.90%

BDX yields 0.07% more than JNJ. In dollar terms, BDX pays $4.24/share vs JNJ's $5.36/share annually.

Dividend Growth

BDX 5yr CAGR
9.3%
accelerating
JNJ 5yr CAGR
5.0%
decelerating

BDX: Dividend growth is accelerating — the 3-year CAGR of 11.6% exceeds the 5-year rate of 9.3% and the 10-year rate of 7.0%.

JNJ: Dividend growth is slowing — the 3-year CAGR of 4.4% trails the 5-year rate of 5.0% and the 10-year rate of 5.3%.

Dividend Safety

BDX
Moderate
Payout Ratio72%
JNJ
At Risk
Payout Ratio80%

BDX: The payout ratio of 72% is moderate. The dividend is currently covered by earnings but leaves less room for growth. Earnings cover the dividend 1.2x.

JNJ: The payout ratio of 80% is elevated, which may indicate the dividend could be cut if earnings decline. Earnings cover the dividend 1.2x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
BDX
JNJ
$10,000
$197/yr
$190/yr
$50,000
$985/yr
$949/yr
$100,000
$1,969/yr
$1,897/yr

What does $10,000 buy in BDX vs JNJ today?

At $215.83 per share, $10,000 buys about 46.3 shares of Becton Dickinson & Co (BDX). Each share pays $4.24 per year in dividends, so the position starts out generating roughly $196 per year — about $16 a month.

At $278.81 per share, $10,000 buys about 35.9 shares of Johnson & Johnson (JNJ). Each share pays $5.36 per year in dividends, so the position starts out generating roughly $192 per year — about $16 a month.

On day one the two positions generate nearly identical income; the difference comes from what happens to each dividend afterward.

What could $10,000 of BDX or JNJ income look like in 10 years?

Becton Dickinson & Co (BDX) has raised its dividend about 9.3% a year over the past five years. If that pace held, the $197 per year that $10,000 generates today at the current 1.97% yield would reach $480 per year by 2036 — a 4.8% yield on the original cost.

Johnson & Johnson (JNJ) has raised its dividend about 5.0% a year over the past five years. If that pace held, the $190 per year that $10,000 generates today at the current 1.90% yield would reach $308 per year by 2036 — a 3.1% yield on the original cost.

On those trailing rates, BDX pays more in 2036: $480 versus $308 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would JNJ's dividend growth overtake BDX's higher yield?

It doesn't, on the trailing numbers. Becton Dickinson & Co (BDX) yields more today (1.97% vs 1.90%) and has also grown its dividend at least as fast (9.3% vs 5.0% a year over five years). Unless JNJ accelerates its raises or BDX stumbles, JNJ never closes the income gap — BDX wins on both current income and growth.

Can BDX and JNJ afford their dividends?

Becton Dickinson & Co (BDX) earns $5.06 per share against $4.24 paid out in dividends — 1.2x coverage (a 72% payout ratio).

Johnson & Johnson (JNJ) earns $6.59 per share against $5.36 paid out in dividends — 1.2x coverage (a 80% payout ratio).

Coverage is similar for both, so neither dividend looks meaningfully more stretched than the other on current earnings.

Which fits an early-retirement income portfolio better, BDX or JNJ?

For income you need right now, Becton Dickinson & Co (BDX) leads: $100,000 invested today pays about $164 a month at the current 1.97% yield, versus $158 a month from Johnson & Johnson (JNJ) at 1.90%.

BDX also leads on dividend growth (9.3% vs 5.0% a year over five years), so the trailing numbers favor it on both fronts.

On consistency: BDX has raised its dividend 42 consecutive years; JNJ has raised its dividend 61 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $584/yr in BDX vs $372/yr in JNJ by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.